$WDLF
Decentral Life Inc

2023 Q2 Form 10-Q Financial Statement

#000149315223015301 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $173.2K $142.8K $292.8K
YoY Change 23.71% 434.76%
Cost Of Revenue $28.04K $16.18K $48.22K
YoY Change 12932.43%
Gross Profit $145.1K $126.6K $244.6K
YoY Change 3.68% 349.72%
Gross Profit Margin 83.81% 88.67% 83.53%
Selling, General & Admin $162.9K $179.8K $78.32K
YoY Change 115.36% 257.49% -63.56%
% of Gross Profit 112.21% 142.04% 32.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $162.9K $179.8K $78.32K
YoY Change 115.36% 257.49% -59.88%
Operating Profit -$17.73K -$53.22K $166.2K
YoY Change -127.54% 5.8% -218.03%
Interest Expense $10.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $6.00 $11.00 $64.42K
YoY Change -100.12% -124.2%
Pretax Income -$17.72K -$53.21K $230.7K
YoY Change -129.91% 5.79% -111.78%
Income Tax
% Of Pretax Income
Net Earnings -$17.72K -$53.21K $230.7K
YoY Change -129.91% 5.78% -111.78%
Net Earnings / Revenue -10.23% -37.27% 78.78%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 7.395B shares 7.395B shares 7.395B shares
Diluted Shares Outstanding 7.675B shares 7.395B shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.2K $217.4K
YoY Change 81304.35% 27775.64%
Cash & Equivalents $31.34K $169.1K $199.3K
Short-Term Investments $18.12K $18.12K
Other Short-Term Assets $18.12K $18.12K
YoY Change
Inventory
Prepaid Expenses
Receivables $485.5K $628.2K
Other Receivables $592.5K $485.5K $628.2K
Total Short-Term Assets $641.9K $672.7K $845.7K
YoY Change 51.74% 84.22% 106.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $641.9K $672.7K $845.7K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $641.9K $672.7K $845.7K
YoY Change 51.74% 84.22% 106.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $720.00
YoY Change -100.0% -98.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.67K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.67K $720.00
YoY Change -79.61% -98.62%
LONG-TERM LIABILITIES
Long-Term Debt $121.7K $251.4K
YoY Change -75.51% -48.73%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $121.7K $251.4K
YoY Change -75.51% -48.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.67K $720.00
Total Long-Term Liabilities $121.7K $251.4K
Total Liabilities $119.3K $132.4K $252.1K
YoY Change -78.23% -75.9% -53.54%
SHAREHOLDERS EQUITY
Retained Earnings -$32.86M -$32.85M -$32.79M
YoY Change -1.93% -2.17%
Common Stock $33.39M $33.39M $33.39M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $522.6K $540.4K $593.6K
YoY Change
Total Liabilities & Shareholders Equity $641.9K $672.7K $845.7K
YoY Change 51.74% 84.22% 106.88%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$17.72K -$53.21K $230.7K
YoY Change -129.91% 5.78% -111.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$124.7K $88.80K $15.72K
YoY Change -9546.97% -1324.79% -110.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.07K -$119.0K -200.0K
YoY Change 748.7% -1876.12% -232.01%
NET CHANGE
Cash From Operating Activities -124.7K $88.80K 15.72K
Cash From Investing Activities
Cash From Financing Activities -13.07K -$119.0K -200.0K
Net Change In Cash -137.8K -$30.20K -184.3K
YoY Change 62522.73% 5391.45% 19504.26%
FREE CASH FLOW
Cash From Operating Activities -$124.7K $88.80K $15.72K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001281984
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55961
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Decentral Life, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0495298
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6400 S. Fiddlers Green Circle
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1180
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
CY2023Q1 dei City Area Code
CityAreaCode
(855)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
933-3277
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7394792892 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169108 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199310 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
485513 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
628238 usd
CY2023Q1 WDLF Security Deposits
SecurityDeposits
18118 usd
CY2022Q4 WDLF Security Deposits
SecurityDeposits
18118 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
672739 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
845666 usd
CY2023Q1 us-gaap Assets
Assets
672739 usd
CY2022Q4 us-gaap Assets
Assets
845666 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
720 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
10673 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
129673 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10673 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
130393 usd
CY2023Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
121700 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
121700 usd
CY2023Q1 us-gaap Liabilities
Liabilities
132373 usd
CY2022Q4 us-gaap Liabilities
Liabilities
252093 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
7394793 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7394793 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25992306 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25992306 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32846734 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-119000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32793526 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
540365 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
672739 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
845666 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142775 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16177 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
126598 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10381 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2816 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
169436 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47483 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
179816 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
50299 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-53218 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-50299 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53208 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-50299 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7394792892 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7675367567 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7394792892 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7675367567 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-133813 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-50299 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-184111 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53208 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
540365 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
540365 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53208 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-50299 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-142725 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-43051 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-720 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88797 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7248 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6700 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
119000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6700 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30203 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-548 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
199310 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
776 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
169108 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
228 usd
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2020Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Additionally, the Amended Articles authorized the Company from May 8, 2020 and continuing until June 30, 2021, as determined by its Board in its sole discretion, to effect a Reverse Stock Split of not less than 1 share for every 5,000 shares and no more than 1 share for every 25,000 shares (the “Reverse Stock Split”)
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zoBughHg6KGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zdpUOM734wE8">Use of estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zGLZQJdMkmWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zVTw3Fi91YJa">Concentrations of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently have not experienced any losses in its accounts. The Company is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
169108 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
199310 usd
CY2018Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Cash
Cash
169108 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32846734 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53208 usd
CY2023Q1 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
since January 1, 2021, or currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds $5,000 or one percent of our total assets at March 31, 2023, and in which any of the following persons had or will have a direct or indirect material interest
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001493152-23-015301-index-headers.html Edgar Link pending
0001493152-23-015301-index.html Edgar Link pending
0001493152-23-015301.txt Edgar Link pending
0001493152-23-015301-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wdlf-20230331.xsd Edgar Link pending
wdlf-20230331_cal.xml Edgar Link unprocessable
wdlf-20230331_def.xml Edgar Link unprocessable
wdlf-20230331_pre.xml Edgar Link unprocessable
wdlf-20230331_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed